Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Gujrathi Sheila, Director. Director active across 2 companies, notably Ventyx Biosciences, Inc.. Aggregated, 8 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €288k. Activity tracked since 25 October 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Gujrathi Sheila is Administrateur at Ventyx Biosciences, Inc. and Janux Therapeutics, Inc. She has 8 filings in total, and across the sampled recent filings, buys total EUR 288096 and sells total EUR 0, between 2021-10-25 and 2026-03-04. The modal transaction nature is Attribution.